Skip to main content

Ending Trials Early

Most clinical trials run as planned from beginning to end. But sometimes trials are stopped early. For example, the IRB and DSMB may stop a trial if participants are experiencing unexpected and severe side effects or if there is clear evidence that the harms are outweighing the benefits.

In some cases, a trial might be stopped because:

  • It is going very well. If there is clear evidence early-on that a new treatment or intervention is effective, then the trial may be halted so that the new treatment can be made widely available as soon as possible.
  • Enough patients cannot be recruited
  • The results of other trials are published that answer the research question or make it irrelevant
  • Reviewed: